Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

The Cure Economy: Cell and Gene Therapy’s Make or Break Moment

ET
60 Minutes

Cell and gene therapy is moving from scientific promise to commercial execution, supported by increasing approvals, a more predictable regulatory environment, renewed investment, and expanding CDMO capacity and expertise. As the field advances in vivo delivery, next generation cell therapies, and iPSC-derived platforms, success increasingly depends not only on whether a therapy works, but whether it can be manufactured reliably, scaled efficiently, and delivered sustainably.

Join us to hear from our panel of experts as they unpack the real technical and operational challenges of advanced therapy development. We’ll exlore:

  • How vector-based, cell-based, and iPSC platforms stack on manufacturability
  • What facility design and capacity planning decisions actually move the needle
  • Where tech transfer and supply chain bottlenecks quietly derail timelines
  • What recent setbacks reveal about the limits of current manufacturing and process control

Speakers

0

Sara Miller

Director, Advanced Therapies Commercial Technical Lead
FUJIFILM Biotechnologies

Sara J. Miller is the Director, Advanced Therapies Commercial Technical Lead at FUJIFILM Biotechnologies, where she leads commercial and CMC teams to design solutions that meet customer needs and ultimately ensure patients receive life-saving therapies. Sara has worked in the biotechnology field for over 15 years and found her niche in CDMOs having previously worked for Emergent BioSolutions, Patheon, and Cognate BioServices. She holds a Bachelor of Science from Grand Valley State University and a Master of Science from Johns Hopkins University. 

0

Delara Motlagh, Ph.D., MBA

President and Chief Operating Officer
FUJIFILM Cellular Dynamics, Inc.

Delara Motlagh is President and CEO of FUJIFILM Cellular Dynamics, Inc., a leading developer and manufacturer of iPSCs. She is responsible for driving enterprise strategy, business performance, and global execution across the discovery research and cell therapy CDMO business units globally. Previously, she held senior leadership roles at Catalent Pharma Solutions, Terumo Blood and Cell Technologies, and Baxter Healthcare. She holds a Ph.D. in Physiology and Biophysics and an M.S. in Biology from the University of Illinois at Chicago, an Executive MBA from Northwestern University’s Kellogg School of Management, and a B.S. in Biology from the University of Illinois at Urbana-Champaign.

0

Nina Bauer, Ph.D., MBA

Executive Vice President, Strategy & Commercial
FUJIFILM Cellular Dynamics, Inc.

Nina G. Bauer is EVP, Strategy & Commercial at FUJIFILM Cellular Dynamics, Inc., where she leads strategy and commercial activities across the discovery research and cell therapy CDMO businesses. Previously, she held senior leadership roles at SmartCella, MilliporeSigma, Lonza, and the Cell and Gene Therapy Catapult, and served as Chief Commercial Officer of FloDesign Sonics. She holds a Ph.D. in Neuroscience from Carl von Ossietzky University of Oldenburg, Germany, an MBA from the University of Edinburgh, Scotland, and an M.A. in Neurobiology from Stony Brook University, NY.

Register here!

Already registered? Click here to login.
Date/Time:
ET